The Parkinson’s Foundation announces centres for ‘under-served’ communities

News

Author: Joe McAweaneyPublished: 29 August 2019

Prep: Cook: Serves:

The Parkinson’s Foundation has announced the addition of three Centres of Excellence to its network of care facilities for people with Parkinson’s.

The centres, which are based in US states Colorado, Indiana and Pennsylvania, will primarily focus on ‘under-served’ (low income) communities which have less access to healthcare services – giving individuals from those areas priority in the application process.

The facilities will include specialised teams of neurologists, movement disorder specialists, mental health professionals and experts in Parkinson’s medication.

John L. Lehr, president of the Parkinson’s Foundation, said: “The newly designated Centers of Excellence join a network that is setting the highest standards of care for people with PD worldwide.

“We are proud to further our commitment to improving the quality of life for people with Parkinson’s and making a difference in under-served communities across the country.”

For more information on Parkinson’s and multidisciplinary care please visit the EPDA website.

To read more about this story click here.

Take part in a global Parkinson’s carers survey

Last Month

Next Month

Go Back

Share this story

Comments

Special reports

Has the pandemic had some positive effects on people with Parkinson’s disease?

Researchers suggest it has improved health-related quality of life

New brain chemical pump is “huge step forward” for advanced Parkinson’s

Approval of new dopamine pump welcomed by campaigners

Why we should treat this ‘damaging’ study on physiotherapy in Parkinson’s with caution

President of APPDE calls PD REHAB trial “damaging”

Is there a link between Parkinson’s disease and blood vessel dysfunction?

Scientists in Slovakia have investigated the link between blood vessel dysfunction and Parkinson’s – and found that dopamine agonists may have an impact. The team studied the function of the endothelium – a membrane which lines the heart and blood vessels and helps control blood fluidity – in 41 people with the condition and 41 people without. Endothelial function was then measured through a parameter that assessed how easily blood could flow through the vessels. The results showed that while more people with Parkinson’s had endothelial dysfunction compared to those without, the difference did not reach statistical significance. However, the researchers noted that the findings suggested “an association between smoking, dopamine agonists, and impaired endothelial function” in those with the condition. Outlining the study’s limitations, the team noted that more research is needed to explore this potential link.

New swab test may help with Parkinson’s disease diagnosis

Researchers at the University of Manchester, UK, have drawn on one woman’s sense of smell to develop a swab test that may be used to detect Parkinson’s. The scientists used the test to analyse sebum (a type of oily substance on the skin) in 79 people with Parkinson’s and a control group of 71 healthy individuals. The team identified more than 4,000 different compounds in the participant samples – including 500 that were unique to those living with the condition. The test was developed with the help of Joy Milne from Perth, Scotland, whose unique sense of smell meant that she noticed a change in her late husband Les’s odour twelve years before he was diagnosed with Parkinson’s. Speaking to the BBC, Professor Perdita Barran, who led the research, described the test as potentially “transformative” – and said that the team hopes to roll the test out to people in…

Could a national biobank help inform the future of Parkinson’s disease treatment in Australia?

A biobank is a collection of biological samples and data designed to be used for research. Now, researchers in Australia are working to build a biobank for Parkinson’s. As part of the project, the scientists are conducting scans of people that have been injected with fluorodopa – a substance that highlights dopamine in the brain. Participants include people living with Parkinson’s and a control group of people without the condition. The resulting database of scans will be used to create a national biobank that aims to inform treatment and research into the condition. Commenting on the study, Olivia Nasser – executive director at the Hospital Research Foundation, which is helping to fund the research – said, “Once we build up the biobank of scans, it can actually be used as an effective way to treat Parkinson’s.” The researchers encourage people with and without Parkinson’s to take part in the trial.

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Comments
This field is for validation purposes and should be left unchanged.

The Parkinson’s Foundation announces centres for ‘under-served’ communities

News

Author: Joe McAweaneyPublished: 29 August 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Special reports

Has the pandemic had some positive effects on people with Parkinson’s disease?

Advances

New brain chemical pump is “huge step forward” for advanced Parkinson’s

Special reports

Why we should treat this ‘damaging’ study on physiotherapy in Parkinson’s with caution

Is there a link between Parkinson’s disease and blood vessel dysfunction?

New swab test may help with Parkinson’s disease diagnosis

Could a national biobank help inform the future of Parkinson’s disease treatment in Australia?

{title}

Subscribe

The Parkinson’s Foundation announces centres for ‘under-served’ communities

News

Author: Joe McAweaneyPublished: 29 August 2019

Last Month

Next Month

Share this story

Comments

Related articles

Special reports

Has the pandemic had some positive effects on people with Parkinson’s disease?

Advances

New brain chemical pump is “huge step forward” for advanced Parkinson’s

Special reports

Why we should treat this ‘damaging’ study on physiotherapy in Parkinson’s with caution

Is there a link between Parkinson’s disease and blood vessel dysfunction?

New swab test may help with Parkinson’s disease diagnosis

Could a national biobank help inform the future of Parkinson’s disease treatment in Australia?

{title}

Subscribe

Sign in